Alofisel®▼ (darvadstrocel) Administration Method

Alofisel® is indicated for the treatment of complex perinal fistulae in adult patients with nonactive/mildly active luminal Crohn's disease, when fistulae have shown an inadequate response to at least one conventional or biologic therapy ⁽¹⁾.  Alofisel should be used after conditioning of fistula.  The below video details the Alofisel® administration method and is provided as part of the product's risk management plan.

View the Alofisel® 5 million cells/mL suspension for injection SmPC & PIL

Ref 1. Alofisel®▼Summary of Product Characteristics, Takeda UK Limited. Available from www.medicines.org.uk. Last accessed July 2018

UK/CX6/1807/0041

Date of Preparation: July 2018